CClinicalTrials.gg
WithdrawnNCT05450445Updated Jul 10, 2025

myHealthHub for Older Adult Inpatients

An interventional study of myHealthHub and TV-only in Patient Engagement, Stress and Loneliness, sponsored by Lady Davis Institute. Withdrawn. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-07-10.

Sponsored by Lady Davis Institute · Not applicable, Interventional, and Supportive care

Why this study was withdrawn
In the post-COVID environment, we had great difficulty convincing a hospital to join us and collaborate with us, so the study was dropped. We did not formally start the study or recruit any participants.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

This study will assess "myHealthhub" in hospitalized older adults throughout 5 days of their hospital stay. The investigators propose a mixed method randomized controlled trial (RCT) comparing myHealthHub platform vs. a simplified HealthHub system that provides only TV access, in order to evaluate patients' loneliness, stress, quality of life, patient engagement, and other mental health outcomes in n=60 older adult inpatients. The investigators will also use qualitative methods to assess user and stakeholder experience, and engagement.

02

Conditions studied

  • Patient Engagement
  • Stress
  • Loneliness
  • Quality of Life

Browse trials for

Keywords

  • Older adults
  • Hospital Inpatients
  • Technology
03

In context

Patient Participation

127 studies on the registry are indexed under Patient Participation; 64 are open to participants now.

Browse Patient Participation studies →

Lead sponsor

Lady Davis Institute is the lead sponsor of 45 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Quantitative Component:

Inclusion Criteria:

  • ≥60 years old
  • Admitted to non-surgical hospital unit
  • Speak English or French
  • Capable of giving consent

Exclusion Criteria:

  • Delirium
  • Active suicidal ideation
  • Moderate/severe dementia diagnosis

Qualitative Component:

Inclusion Criteria:

  • Participants from quantitative component
  • Hospital staff, nurses, clinicians facilitative use of the service
  • ≥18 years old
  • Speak English or French

Exclusion Criteria:

  • Hospital staff, nurses, clinicians who do not have experience with the service
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Intervention: myHealthHub

    Device: myHealthHub

  • Active comparator
    Active control: TV-only

    Device: TV-only

Interventions

  • DevicemyHealthHub

    myHealthHub is a multimodal patient engagement platform delivered on bedside terminals to provide hospital inpatients with social connection, meal ordering services, entertainment (TV, etc.), and access to medical care team.

  • DeviceTV-only

    myHealthHub device equipped with the TV-only entertainment option.

06

What researchers measure

Primary outcomes

  1. Changes in Loneliness

    Loneliness measured by the UCLA 3-item Loneliness Scale (UCLA-3). This is a 3-item scale with scores ranging from 3-9, with higher scores indicating greater severity of loneliness.

    Time frame: Baseline, day 2, day 3, day 4, day 5

Secondary outcomes

  1. Changes in Stress

    Stress measured by Perceived Stress Scale (PSS). This is a 14-item scale with scores ranging from 0-56, with higher scores indicating greater severity of stress.

    Time frame: Baseline, day 3, day 5

  2. Changes in Patient Engagement

    Patient engagement measured by Patient Activation Measure-13 (PAM-13). This is a 13-question scale.

    Time frame: Baseline, day 3, day 5

  3. Changes in Quality of Life in Older Adults

    Quality of life which will be measured by the Euro-Quality of Life (EQ-5D). This is a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.

    Time frame: Baseline, day 3, day 5

Other outcomes

  1. Feasibility Outcome: Enrollment

    Enrollment rate (percent of participants enrolled from eligible participants)

    Time frame: Day 5

  2. Feasibility Outcome: Recruitment

    Recruitment target (ability to recruit 60 participants)

    Time frame: Day 5

  3. Feasibility Outcome: Retention

    Retention rate (percent of randomized participants who complete 5-day assessments in both arms)

    Time frame: Day 5

  4. Exploratory Outcome: Changes in Depression

    Depression measured by the Patient Health Questionnaire-9 (PHQ-9). This is a 9-question scale with scores ranging from 0-27, with higher scores indicating greater severity of depression.

    Time frame: Baseline, day 5

  5. Exploratory Outcome: Changes in Anxiety

    Anxiety measured by Generalized Anxiety Disorder-7 (GAD-7) scale. This is a 7-question scale with scores ranging from 0-21, with higher scores indicating greater severity of anxiety.

    Time frame: Baseline, day 5

  6. Qualitative Component: Semi-structured interviews

    The qualitative outcome of this RCT will analyze the experiences, barriers, and engagement of older adults with the myHealthHub device. It will also explore the experiences and limitations of hospital support staff with myHealthHub service.

    Time frame: Day 5

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05450445
Lead sponsor
Lady Davis Institute
Responsible party
Soham Rej MD, MSc (Principal Investigator, Lady Davis Institute) — Principal investigator
First posted
Jul 8, 2022
Start date
Sep 1, 2022 (estimated)
Primary completion
Sep 1, 2023 (estimated)
Completion
Sep 1, 2023 (estimated)
Last update
Jul 10, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion